A prognostic scoring system that is cheap, efficient and reliable can predict how patients with relapsed and/or metastatic head and neck cancer will respond to immunotherapy, new research has shown.
Jul 22, 2021
0
5
During the height of the pandemic, some hospitals were overwhelmed with patients seeking treatment for COVID-19. This situation could happen again during future outbreaks, especially with SARS-CoV-2 variants of concern on ...
Jul 21, 2021
0
0
The latest investigations into a promising new genetic test for glaucoma—the leading cause of blindness worldwide—has found it has the ability to identify 15 times more people at high risk of glaucoma than an existing ...
Jul 15, 2021
0
4
Despite the availability of numerous effective birth control methods, more than 40 percent of pregnancies worldwide are unintended. In addition to contributing significantly to population growth, unintended pregnancies can ...
Jul 13, 2021
0
2
(HealthDay)—The percentage of males and nonpregnant females aged ≥13 years with commercial insurance or Medicaid who received HIV testing increased from 2014 to 2019, but remained below 6 percent, according to research ...
Jun 28, 2021
0
2
Four years ago, researchers in the CRUK TRACERx team at the Crick and UCL, alongside an industry-collaborator Natera, developed a personalized test that uses circulating fragments of tumor DNA (ctDNA) in the blood of patients ...
Jun 28, 2021
0
2
A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment ...
Jun 23, 2021
0
3
In the fight against viruses, antibodies have the potential to either block infection or enable infection and make the disease worse, leading to concern about their use as a therapy for COVID-19.
Jun 21, 2021
0
27
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a clinical study led by ...
Jun 21, 2021
0
22
In a highly anticipated announcement, the U.S. Food and Drug Administration on Monday, June 7, approved the first new drug for Alzheimer's disease in nearly two decades.
Jun 15, 2021
0
2
